Mesoblast (MESO) FCF Margin (2016 - 2023)

Mesoblast's (MESO) quarterly FCF Margin came in at 2056.32% in Q2 2023, up 552128.0% year-on-year from N/an in Q2 2022, and up 145.37% quarter-over-quarter from 838.06% in Q1 2023.

Mesoblast (MESO) FCF Margin (2016 - 2023) Analysis & Trends

Mesoblast has disclosed FCF Margin across 8 years of filings, most recently posting 2056.32% for Q2 2023.

  • FCF Margin for Q2 2023 came in at 2056.32%, up 552128.0% year-over-year; the trailing twelve-month figure through Mar 2023 was 807.02% (up 108979.0% YoY), and the FY2025 annual result was 294.69%, changed N/A from the prior year.
  • FCF Margin came in at 2056.32% for Q2 2023 at Mesoblast, up from 838.06% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 7108.63% in Q1 2021 to a low of 9147.19% in Q2 2021.
  • The 5-year median for FCF Margin is 760.34% (2021), against an average of 272.5%.
  • Peak annual rise in FCF Margin reached 615260 bps in 2021, while the deepest fall reached 881480 bps in 2021.
  • Mesoblast's FCF Margin stood at 67.55% in 2019, then sank by 2120 bps to 1364.57% in 2020, then soared by 44 bps to 764.86% in 2021, then jumped by 209 bps to 831.01% in 2022, then surged by 147 bps to 2056.32% in 2023.
  • The last three FCF Margin figures came in at 2056.32% (Q2 2023), 838.06% (Q1 2023), and 831.01% (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -3.98%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 43.35%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Mesoblast 21.68 Bn 21.55 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 2,056.32%
Mar 31, 2023 838.06%
Dec 31, 2022 831.01%
Sep 30, 2022 990.09%
Jun 30, 2022 -3,464.96%
Mar 31, 2022 769.27%
Dec 31, 2021 -764.86%
Sep 30, 2021 751.40%
Jun 30, 2021 -9,147.19%
Mar 31, 2021 7,108.63%
Dec 31, 2020 -1,364.57%
Sep 30, 2020 -2,158.39%
Jun 30, 2020 -332.40%
Mar 31, 2020 956.03%
Dec 31, 2019 67.55%
Sep 30, 2019 831.09%
Jun 30, 2019 -4,905.64%
Mar 31, 2019 2,033.49%
Dec 31, 2018 -166.72%
Sep 30, 2018 1,942.74%